Skip to main content
. 2024 Mar 13;22:115. doi: 10.1186/s12916-024-03302-5

Table 2.

Association between metabolic syndrome and dementia risk

Variable All-cause dementia Alzheimer’s disease Vascular dementia
Non-MetS MetS Non-MetS MetSe Non-MetS MetSe
Cases, n 4597 2248 2002 883 925 600
Person-years 4,422,910 1,374,613 4,428,013 1,377,299 4,430,434 1,378,035
Incidence ratea 103.94 163.54 45.21 64.11 20.88 43.54
Model 1b, HR (95% CI) 1.00 (Ref) 1.25 (1.19–1.31)* 1.00 (Ref) 1.11 (1.02–1.20)* 1.00 (Ref) 1.64 (1.48–1.82)*
Model 2c, HR (95% CI) 1.00 (Ref) 1.11 (1.05–1.17)* 1.00 (Ref) 1.01 (0.93–1.09) 1.00 (Ref) 1.41 (1.27–1.57)*
Model 3d, HR (95% CI) 1.00 (Ref) 1.06 (1.01–1.12)* 1.00 (Ref) 0.98 (0.90–1.07) 1.00 (Ref) 1.28 (1.15–1.43)*

MetS, metabolic syndrome

*P-value < 0.05

aPer 100,000 person-years

bModel 1, stratified by age, gender, and UK Biobank assessment center

cModel 2, additionally adjusted for race (white or other), index of multiple deprivation (a measure of socioeconomic status), smoking status (never smoked, previous smoker, current smoker), alcohol consumption (never or special occasions only, one to three times a month, one to four times a week, daily or almost daily), physical activity (high, low, moderate, or unknown/missing), portions of fruit and vegetable intake (< 5 portions per day, ≥ 5 portions per day, or unknown/missing)

dModel 3, fully adjusted model additionally adjusted for regular medications [multivitamin use (yes or no), mineral supplement (yes or no), non-steroidal anti-inflammatory drugs (yes or no), aspirin (yes or no)], and history of Alzheimer’s disease/dementia (yes or no)